Proteasome Inhibitors Evoke Latent Tumor Suppression Programs in Pro-B MLL Leukemias Through MLL-AF4

Cancer Cell - United States
doi 10.1016/j.ccr.2014.03.008
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

A Mouse Model Reveals Lineage Plasticity in MLL–AF4 Pro-B ALL

Cancer Discovery
Oncology
2016English

circRNA circAF4 Functions as an Oncogene to Regulate MLL-AF4 Fusion Protein Expression and Inhibit MLL Leukemia Progression

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

Inhibition of Class I HDACs Abrogates the Dominant Effect of MLL-AF4 by Activation of Wild-Type MLL

Oncogenesis
Cancer ResearchMolecular Biology
2014English

Protean Clinical Manifestations in Children With Leukemias Containing MLL-AF10 Fusion

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2000English

Paradoxical Effects of MLL Paralogs in MLL-Rearranged Leukemia

Cancer Cell
Cancer ResearchOncologyCell Biology
2017English

Proteomics-Based Strategy to Identify Biomarkers and Pharmacological Targets in MLL/AF4 Leukemia

English

MLL Gene Alterations in Acute Myeloid Leukaemia (11q23/Mll+ AML)

2013English

MLL Fusion Driven Activation of CDK6 Potentiates Proliferation in MLL-rearranged Infant ALL

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

Identification of MLL-fusion/MYC⊣miR-26⊣TET1 Signaling Circuit in MLL-rearranged Leukemia

Cancer Letters
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy